1. Thailand Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
SMD Rise Public Company Limited

SMD Rise Public Company Limited

1.58
THB
+0.03
(+1.94%)
0.23EPS
4.59P/E
222.24MMarket Cap
Nov 18Next Earn
SMD Rise Public Company Limited
SET:SMD100.R
(Stock Exchange of Thailand)

Recent

price

1.58

P/E

ratio

4.59

div

yld

3.91%

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
THB
- -
3.68
3.93
8.16
8.94
3.7
3.81
4.38
5.2
Revenue per Share
- -
0.36
0.46
1.61
1.32
0.35
0.2
0.05
0.23
Basic EPS, GAAP
- -
0.5
0.11
0.71
2.07
0.09
-0.47
-0.74
-0.19
Free Cash Flow per Basic Share
- -
0.07
0.54
0.12
0.73
0.65
0.65
0.25
0.06
Dividend per Share
0.85
1.03
1
3.98
4.57
4.2
3.66
3.45
3.38
Book Value per Share
0.82
1.02
0.99
3.98
4.57
4.19
3.66
3.43
3.35
Tangible Book Value per Share
225
168
168
199
225
224
208
208
210
Basic Weighted Avg Shares
- -
619
661
1,621
2,010
827
793
910
1,091
Sales/Revenue/Turnover
- -
13.71
15.94
25.51
18.6
11.66
8.45
4.1
7.72
Operating Margin (%)
- -
27
28
29
31
31
35
46
57
Depreciation Expense
- -
60
78
320
297
79
42
11
49
Net Income, GAAP
- -
20.55
19.43
19.18
19.01
15.33
30.45
56.17
26.12
Effective Tax Rate (%)
- -
9.77
11.76
19.72
14.76
9.58
5.25
1.17
4.49
Profit Margin (%)
32
90
109
726
850
699
509
425
387
Working Capital
10
2
73
51
48
43
67
101
83
LT Debt
191
232
224
895
1,028
900
760
716
701
Total Equity
- -
17.19
19.21
38.25
25.99
8.04
4.71
1.57
6.34
Return on Invested Capital (%)
- -
18.76
19.44
38.89
26.88
8.09
4.7
1.57
5.95
Return on Capital (%)
- -
28.61
34.13
57.12
30.85
8.22
5.02
1.44
7.15
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
227
241
240
LT Borrowings
27
23
28
LT Finance Leases
75
72
55
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
208
208
208
Market Capitalization
494
363
222

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
953
917
893
Cash, Cash Equivalents & STI
48
114
68
Accounts Receivable, Net
274
180
279
Inventories
433
467
380
Total Current Liabilities
528
553
506
Payables & Accruals
293
308
261
ST Debt
227
241
240
Deferred Revenue
2
1
2

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
56.18%
-5.77%
Free Cash Flow
- -
60.18%
57.83%
Net Income, GAAP
- -
21.75%
-74.53%
Sales/Revenue/Turnover
- -
24.2%
14.75%
Total Cash Common Dividend
- -
85.26%
-61.58%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
139
180
252
222
793
2025
152
161
344
253
910
2026
173
321
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
0.03
0.14
0.09
0.2
2025
-0.13
-0.07
0.14
0.1
0.05
2026
-0.15
0.13
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.15
- -
0.5
0.65
2025
- -
0.26
- -
- -
0.25
2026
- -
0.06
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
SMD Rise Public Company Limited engages in the import, distribution, and sale of medical devices, equipment, and supplies to private hospitals, clinics, and the general public in Thailand. It provides sleep testing services; rental, hire purchase, and leasing of medical equipment; and wellness equipment services. The company also imports and distributes products related to radiology and other medical products, including diagnostic instruments, laboratory equipment, reagents, and related accessories. SMD Rise operates through a network of distributors and service centers across Thailand, with headquarters in Nonthaburi and a founding year of 1998. It has pursued strategic corporate actions including the establishment of subsidiaries to broaden its end-to-end medical solutions, expand its product categories, and enhance after-sales services, with a focus on enabling comprehensive medical technology distribution and support in the Thai market. The company previously traded under the SaintMed name before rebranding to SMD Rise Public Company Limited in 2025, aligning its identity with an expanded portfolio and future growth initiatives in medical devices, diagnostics, and related services. Subsidiaries and strategic partnerships are part of its recent actions to strengthen regional reach and product offerings, including ventures into medical endoscopic equipment distribution and associated maintenance and calibration services slated to commence revenue in late 2026, underscoring an emphasis on integrated medical technology solutions for healthcare providers. Overall, SMD Rise positions itself as a Thailand-based medical devices distributor and service provider with a broad product scope, expanding geographic and product breadth through corporate actions and new entity formations.